HomepageMedicineReviR Therapeutics Partners with Kennedy’s Disease Association for New Molecule Development Medicine ReviR Therapeutics Partners with Kennedy’s Disease Association for New Molecule Development admin Posted on November 30, 2024 The two companies will work to develop treatments for SBMA. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostAlex Likes a Fresh Bowl: Litter Box Cleaning with 5 Cats Next PostIt All Started With an Unexpected Hug and a Selfie You Might Also Like Medicine FDA Clears Investigational New Drug Application for Actinium Pharmaceuticals’ Iomab-ACT in Patients with Sickle Cell Disease admin July 27, 2024 Medicine Solving the First Mile Problem: Q&A with Mark Melton admin April 29, 2024 Medicine Moderna Releases Promising Data from Phase I/II Clinical Trial on mRNA-3927 for Propionic Acidemia admin April 5, 2024 Medicine IMU-856 Shows Promise in Celiac Disease: Histologic Protection and Nutrient Absorption Key to Advancing Trials admin February 1, 2025
Medicine FDA Clears Investigational New Drug Application for Actinium Pharmaceuticals’ Iomab-ACT in Patients with Sickle Cell Disease admin July 27, 2024
Medicine Moderna Releases Promising Data from Phase I/II Clinical Trial on mRNA-3927 for Propionic Acidemia admin April 5, 2024
Medicine IMU-856 Shows Promise in Celiac Disease: Histologic Protection and Nutrient Absorption Key to Advancing Trials admin February 1, 2025